PeptiCol EZgraft in the Extraction Socket Preservation Process After Tooth Extraction
ConditionAlveolar Ridge Augmentation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-75
SponsorNIBEC Co., Ltd.
About this trial
This clinical trial aims to compare the efficacy and safety of applying "PeptiCol EZgraft" in extraction socket preservation procedures against "Regenomer," in terms of reducing the amount of alveolar bone change during the healing process following tooth extraction.
Eligibility criteria
Qualifiers
Adults aged 19 to 75 years.
Systemically healthy or with mild systemic disease, classified as ASA I or II.
Planning to place implants in the maxilla or mandible after extraction, or having such plans for the future. If there are multiple extraction sockets, only one socket will be included in the trial, and other areas will follow spontaneous healing or treatment plans.
The extraction socket area must have more than 50% of the alveolar bone wall remaining.
Disqualifiers
Extensive alveolar bone absorption observed in the extraction socket area.
Severe periodontal disease or acute periodontal abscess.
Poor oral hygiene.
History of bone grafts or implants in the area of the medical device application.
Trial design
Treatments tested in this trial
- Peptide-loaded collagen sponge and collagen gel complex
- Collagen sponge
Treatment groups
114 Participants
are divided into 2 treatment groupsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Seoul National University Dental HospitalRecruiting03080, Korea, SeoulSouth Korea
Sponsors and collaborators
Source ClinicalTrials.gov